Enliven Therapeutics, Inc. ($ELVN)
Hohl Benjamin โ CHIEF FINANCIAL OFFICER
Shares
6,018
Price
$2.48
Total Value
$14,924.64
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Hohl Benjamin |
|---|---|
| Title | CHIEF FINANCIAL OFFICER |
| Transaction Date | Jun 17, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jun 22, 2026 |
| Shares Purchased | 6,018 |
| Price per Share | $2.48 |
| Total Value | $14,924.64 |
| Shares Owned After | 57,018 |
| Derivative | No |
| Accession Number | 0001882764-26-000005 |
| Document | View SEC Filing |